Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Myrexis89bioAdvanz PharmaAeolus PharmaceuticalsAffymax
SymbolOTCMKTS:MYRXNASDAQ:ETNBOTCMKTS:CXRXFOTCMKTS:AOLSOTCMKTS:AFFY
Price Information
Current Price$0.01$21.40$3.00$0.00$0.02
52 Week RangeN/ABuyN/AN/AN/A
Analyst Ratings
Consensus RecommendationN/ABuyN/AN/AN/A
Consensus Price TargetN/A$46.00N/AN/AN/A
% Upside from Price TargetN/A114.95% upsideN/AN/AN/A
Trade Information
Market CapN/AN/AN/AN/AN/A
Beta3.5N/AN/A2.042.63
Average Volume84,738N/AN/A86,06150,064
Sales & Book Value
Annual RevenueN/AN/A$508.32 millionN/AN/A
Price / SalesN/AN/A0.29N/AN/A
CashflowN/AN/AN/AN/AN/A
Price / CashN/AN/AN/AN/AN/A
Book ValueN/A$6.92 per share$4.02 per shareN/AN/A
Price / BookN/AN/A0.75N/AN/A
Profitability
Net IncomeN/A$-57,420,000.00$-196,020,000.00N/AN/A
EPSN/A($24.49)N/AN/AN/A
Trailing P/E Ratio0.00N/AN/A0.000.00
Forward P/E RatioN/A
P/E GrowthN/AN/AN/AN/AN/A
Net MarginsN/AN/A-38.56%N/AN/A
Return on Equity (ROE)N/AN/A-38.71%N/AN/A
Return on Assets (ROA)N/AN/A-2.50%N/AN/A
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity RatioN/AN/AN/AN/AN/A
Current RatioN/A17.00%2.23%N/AN/A
Quick RatioN/A17.00%1.92%N/AN/A
Ownership Information
Institutional Ownership PercentageN/A77.70%N/AN/AN/A
Insider Ownership Percentage0.01%N/AN/A66.60%1.55%
Miscellaneous
Employees11343542
Shares OutstandingN/A12.99 million48.91 millionN/AN/A
Next Earnings DateN/A6/17/2020 (Estimated)5/8/2020 (Estimated)N/AN/A
OptionableNot OptionableNot OptionableOptionableNot OptionableNot Optionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel